Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells

Abstract : DNA methyltransferases (DNMTs) are important enzymes involved in epigenetic control of gene expression and represent valuable targets in cancer chemotherapy. A number of nucleoside DNMT inhibitors (DNMTi) have been studied in cancer, including in cancer stem cells, and two of them (azacytidine and decitabine) have been approved for treatment of myelodysplastic syndromes. However, only a few non-nucleoside DNMTi have been identified so far, and even fewer have been validated in cancer. Through a process of hit-to-lead optimization, we report here the discovery of compound 5 as a potent non-nucleoside DNMTi that is also selective toward other Ado Met-dependent protein methyltransferases. Compound 5 was potent at single-digit micromolar concentrations against a panel of cancer cells and was less toxic in peripheral blood mononuclear cells than two other compounds tested. In mouse medulloblastoma stem cells, 5 inhibited cell growth, whereas related compound 2 showed high cell differentiation. To the best of our knowledge, 2 and 5 are the first non-nucleoside DNMTi tested in a cancer stem cell line.
Type de document :
Article dans une revue
Journal of Medicinal Chemistry, American Chemical Society, 2014, 57 (3), pp.701-713. 〈10.1021/jm4012627〉
Domaine :
Liste complète des métadonnées

https://hal.univ-lorraine.fr/hal-01494552
Contributeur : Srsmc Ul <>
Soumis le : jeudi 23 mars 2017 - 16:19:39
Dernière modification le : lundi 5 février 2018 - 15:22:13

Lien texte intégral

Identifiants

Collections

Citation

Sergio Valente, Yiwei Liu, Michael Schnekenburger, Clemens Zwergel, Sandro Cosconati, et al.. Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells. Journal of Medicinal Chemistry, American Chemical Society, 2014, 57 (3), pp.701-713. 〈10.1021/jm4012627〉. 〈hal-01494552〉

Partager

Métriques

Consultations de la notice

48